MALAT1 and malignant colon neoplasm: MALAT1 is also increased in colon cancer cells, directly binding to miR-663a, thus acting as a competing endogenous lncRNA; as a result, important cancer-related miR-663a targets (TGFB1, PIK3CD, P21, JunB, and JunD) were affected [86].